SCHEMBL4803775

SCHEMBL4803775

Fc1cccc(COc2ncc(-c3ccc(CS)cc3Cl)c(-c3ccc(Cl)cc3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 12/20 0.39
CNR2 P34972 1/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 3/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALOX5 P09917 1/20 0.37
ALOX5AP P20292 1/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PKM P14618 1/20 0.37
STIM1 Q13586 1/20 0.36
ORAI1 Q96D31 1/20 0.36
GRM5 P41594 1/20 0.35
DPP4 P27487 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4812936 0.92 CNR1 (0.45) CNR1CNR2
SCHEMBL4808893 0.91 CNR1 (0.46) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL4807904 0.89 CNR1 (0.49) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL4811623 0.89 ALDH1A1 (0.41) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL14107191 0.85 CNR1 (0.40) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL4803769 0.85 ALDH1A1 (0.38) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL4810400 0.83 CNR1 (0.53) CNR1CNR2
SCHEMBL4802335 0.82 CNR1 (0.54) CNR1CNR2ALDH1A1CYP1A2USP2
SCHEMBL14153824 0.82 CNR1 (0.54) CNR1CNR2DPP4
SCHEMBL4801542 0.81 CNR1 (0.55) CNR1CNR2ALDH1A1CYP1A2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 US disclosed
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 US disclosed
US-20050245554-A1 Substituted pyrimidines MERCK SHARP & DOHME CORP. 2005-11-03 US disclosed
EP-1546115-A2 SUBSTITUTED PYRIMIDINES Merck & Co., Inc. (US) 2005-06-29 EP disclosed
WO-2004029204-A2 SUBSTITUTED PYRIMIDINES MERCK & CO., INC. (US) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245554-A1 Substituted pyrimidines CNR1, CNR2, GPR119 CNR1 1/4885CNR2 2/4885ALDH1A1 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.